US · OMDA
Omada Health
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- San Francisco, CA 94111
- Website
- omadahealth.com
Price · as of 2026-07-02
$22.39
Market cap 1.09B
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $0.00 | $0.00 | |||
| 2025 | $2.61 | $0.00 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| OMDA | Omada Health | $22.39 | 1.09B | — | — | -88% | — | — | — | — | — | — |
| BCRX | BioCryst Pharmaceuticals,… | $9.10 | 1.91B | +951% | +1,429% | -37% | +1,257% | 6.86 | -15.20 | 2.07 | 4.45 | 9410.00% |
| MAZE | Maze Therapeutics, Inc. | $26.40 | 1.46B | — | -73% | -60% | — | 10.06 | 2.67 | 3.14 | 5.84 | — |
| OMCL | Omnicell, Inc. | $44.72 | 2.03B | +22% | -61% | -75% | -99% | 924.00 | 1.54 | 1.60 | 19.91 | 653.00% |
| PGNY | Progyny, Inc. | $25.69 | 2.01B | +89% | -64% | -64% | -52% | 25.63 | 2.91 | 1.16 | 12.09 | 1040.00% |
| PHR | Phreesia, Inc. | $9.45 | 583.77M | — | — | -68% | -91% | — | — | — | — | — |
| SDGR | Schrödinger, Inc. | $14.16 | 1.06B | +142% | -60% | — | — | -8.64 | 2.45 | 3.49 | -6.29 | 2329.00% |
| TDOC | Teladoc Health, Inc. | $7.51 | 1.36B | +249% | -55% | -92% | — | -4.54 | 0.66 | 0.36 | 7.86 | -154.00% |
| TXG | 10x Genomics, Inc. | $27.99 | 3.55B | +99% | -63% | -84% | — | -66.29 | 3.63 | 4.49 | -22.74 | 525.00% |
| UFPT | UFP Technologies, Inc. | $227.99 | 1.76B | -48% | -12% | -68% | +5% | 23.04 | 3.71 | 2.61 | 14.60 | 1950.00% |
| XERS | Xeris Biopharma Holdings,… | $6.32 | 1.09B | — | — | — | -97% | — | — | — | — | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $22.39) − 1 = — (DCF, example).